Old Web
English
Sign In
Acemap
>
authorDetail
>
Kurt Eng
Kurt Eng
Millennium Pharmaceuticals
Melanoma
Raf Kinase Inhibitor
Cancer research
Mutant
Kinase
3
Papers
3
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Abstract A093: Potential combination partners for a novel CDC7-selective Inhibitor, TAK-931
2019
Molecular Cancer Therapeutics
Kenichi Iwai
Kurt Eng
Tadahiro Nambu
Jie Yu
Masamitsu Gotou
Sakiyo Tsukamoto
Saomi Murai
Shun-ichiro Kageyama
Yukie Kashima
Susumu Kobayashi
Akihiro Ohashi
Show All
Source
Cite
Save
Citations (0)
Abstract C146: Combination treatment with the investigational RAF kinase inhibitor MLN2480 and the investigational MEK kinase inhibitor TAK-733 inhibits the growth of BRAF mutant and RAS mutant preclinical models of melanoma and CRC.
2013
Molecular Cancer Therapeutics
Elizabeth Grace Carideo Cunniff
Julie Zhang
Jouhara Chouitar
Jerome Mettetal
Kazuhide Nakamura
Takeo Arita
Akito Nakamura
Masanori Okaniwa
Tomoyasu Ishikawa
Sei Yoshida
Robyn Fabrey
Patrick Vincent
Kurt Eng
Khristofer Garcia
Deanna Borelli
Teena Vagrhese
Steve Stroud
Saurabh Menon
Mike Kuranda
Katherine M. Galvin
Show All
Source
Cite
Save
Citations (3)
Use of combination treatment with the investigational RAF kinase inhibitor MLN2480 and the investigational MEK kinase inhibitor TAK-733 on the growth of BRAF-mutant and RAS-mutant preclinical models of melanoma and CRC.
2013
Journal of Clinical Oncology
Elizabeth Grace Carideo Cunniff
Julie Zhang
Jouhara Chouitar
Jerome Mettetal
Kazuhide Nakamura
Takeo Arita
Akito Nakamura
Masanori Okaniwa
Tomoyasu Ishikawa
Sei Yoshida
Robyn Fabrey
Patrick Vincent
Kurt Eng
Khristofer Garcia
Deanna Borrelli
Teena Vagrhese
Steve Stroud
Saurabh Menon
Mike Kuranda
Katherine M. Galvin
Show All
Source
Cite
Save
Citations (0)
1